HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Clinical trials for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one surgery be enough? new trial aims to cut unnecessary procedures for bladder cancer patients
Disease control Recruiting nowThis study compares a newer, single surgery using special dye and light (PDD-TURBT) against the standard approach of two surgeries for early-stage bladder cancer. About 112 adults with non-muscle invasive bladder cancer will be randomly assigned to either the new single-surgery m…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE4 • Sponsor: University of Roma La Sapienza • Aim: Disease control
Last updated May 17, 2026 01:46 UTC
-
New vaccine combo shows promise for tough bladder cancer
Disease control Recruiting nowThis early-stage trial tests a new vaccine (IO102-IO103) plus the immunotherapy drug pembrolizumab in 30 adults with a high-risk bladder cancer that did not respond to or could not tolerate standard BCG therapy. The vaccine aims to train the body's immune cells to recognize and a…
Matched conditions: HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated May 17, 2026 01:45 UTC